MYDA Advisors’s Insmed INSM Stock Holding History

MYDA Advisors’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-25,000	Closed	-$2.52M	–	188
2025 Q2	$2.52M	Buy	+25,000	New	+$1.91M	0.44%	61

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

MYDA Advisors's INSM Position: Q1 2026 in Review

MYDA Advisors reduced its Insmed (INSM) stake by 42% in Q1 2026, selling an estimated $769K and leaving 7,000 shares worth $1.14M. The position accounts for 0.19% of the portfolio, ranked #101.

MYDA Advisors first reported a position in INSM in Q3 2024 and has held it in 6 quarters since. The position peaked at $3.22M in Q2 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

MYDA Advisors held 7,000 shares of Insmed worth $1.14M as of Q1 2026.
MYDA Advisors sold 5,000 Insmed shares in Q1 2026, an estimated $769K.
Insmed made up 0.19% of MYDA Advisors's portfolio in Q1 2026, its #101 holding.
MYDA Advisors first reported a position in Insmed in Q3 2024 and has held it in 6 quarters since.
MYDA Advisors's Insmed position peaked at $3.22M in Q2 2025.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on MYDA Advisors's 13F filing for Q1 2026, filed 14 May 2026.